Emerge Australia's InfoLine

Emerge Australia offers a free national InfoLine service for the ME/CFS community, including members, anyone living with ME/CFS, carers and healthcare practitioners.

The InfoLine is available during business hours, Monday to Friday, for the ME/CFS community to ask questions, seek information and connect with us.

Common queries include:

information about ME/CFS
support group details (in-person and online) around Australia
telehealth nurse appointment bookings
general advice
membership
donations

Get in touch with our helpful team today to connect, learn more and share your experience.

You can contact the InfoLine on (03) 9529 1344 or email us.

Latest

Research Digest 10/01/20

Welcome to the 38th edition, featuring a Nature paper examining blood lactate levels in ME/CFS patients whilst at rest and a paper investigating the effect of pharmaceutical intervention on NK cell cytotoxicity in ME/CFS patients compared to healthy individuals.
Meg's 50th Birthday Fundraiser

I'm fundraising to give hope and help to the 250,000 people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across Australia. ME/CFS sorely lacks funding for advocacy, patient support and research, so anything you can contribute would be welcome.
Siobhan's 30th Birthday Fundraiser

I'm fundraising to give hope and help to the 250,000 people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across Australia.
Bunnings Sausage Sizzle Raises Money for Emerge Australia

'We just wanted to do something for our daughter who was diagnosed about five years ago with sudden onset ME/CFS,' Peter and Bronwyn said. '...after considering a few different options for raising money, we thought about a Bunnings BBQ.'

Accessibility
Siobhan's 30th Birthday Fundraiser

I'm fundraising to give hope and help to the 250,000 people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across Australia.
Bunnings Sausage Sizzle Raises Money for Emerge Australia

'We just wanted to do something for our daughter who was diagnosed about five years ago with sudden onset ME/CFS,' Peter and Bronwyn said. '...after considering a few different options for raising money, we thought about a Bunnings BBQ.'
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
Research Digest 10/01/20

Welcome to the 38th edition, featuring a Nature paper examining blood lactate levels in ME/CFS patients whilst at rest and a paper investigating the effect of pharmaceutical intervention on NK cell cytotoxicity in ME/CFS patients compared to healthy individuals.
Treatment and management

The goal of treatment for people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) is to improve a patient's quality of life and to provide relief from symptoms.
Health and Wellbeing Survey

Emerge Australia published results from its first ME/CFS Health and Wellbeing Survey in 2018 and launched another survey in 2019. We plan to stay current and informed about the needs of the ME/CFS community by running an updated version of this Health and Wellbeing Survey every three years.
Disability Support Pension

The Disability Support Pension (DSP) is a Centrelink payment providing financial support if you have a physical, intellectual or psychiatric condition that stops you from working. Click here to access resources developed to assist people with ME/CFS to understand DSP and what is required to apply.
National Disability Insurance Scheme

The National Disability Insurance Scheme (NDIS) is designed to help support people with disability. Click here to access resources developed to assist people with ME/CFS to understand the NDIS and what is required to apply.
Research Digest 17/05/19

Welcome to the 23rd edition, featuring articles on the validation of impaired transient receptor potential melastatin 3 ion channel activity in natural killer cells from ME/CFS patients, and markers of non-coeliac wheat sensitivity in patients with ME/CFS.